161 related articles for article (PubMed ID: 31040200)
21. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
22. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y
BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
[TBL] [Abstract][Full Text] [Related]
25. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
26. Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Wang J; Kang M; Qin YT; Wei ZX; Xiao JJ; Wang RS
Int J Clin Exp Pathol; 2015; 8(6):6936-43. PubMed ID: 26261581
[TBL] [Abstract][Full Text] [Related]
27. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
28. Novel potential markers of nasopharyngeal carcinoma for diagnosis and therapy.
Tang F; Xie C; Huang D; Wu Y; Zeng M; Yi L; Wang Y; Mei W; Cao Y; Sun L
Clin Biochem; 2011 Jun; 44(8-9):711-8. PubMed ID: 21402064
[TBL] [Abstract][Full Text] [Related]
29. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
30. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
32. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
[TBL] [Abstract][Full Text] [Related]
33. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
36. Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.
Yu BB; Lin GX; Li L; Qu S; Liang ZG; Chen KH; Zhou L; Lu QT; Sun YC; Zhu XD
Med Sci Monit; 2018 Apr; 24():2317-2329. PubMed ID: 29664897
[TBL] [Abstract][Full Text] [Related]
37. The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects.
Song XM; Wang ZJ; Cao WJ; Ji-Li ; Chen F; Wang SZ
Int J Clin Oncol; 2016 Dec; 21(6):1038-1045. PubMed ID: 27405513
[TBL] [Abstract][Full Text] [Related]
38. The predictive value of serum lipids for eye metastases in male nasopharyngeal carcinoma patients.
Xie Z; Shao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32584390
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
40. High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma.
Zhao Y; Shen L; Huang X; Jing D; Huang D; Fu J; Li Z; Zhang G; Shen L
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):390-396. PubMed ID: 28947213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
